{
    "clinical_study": {
        "@rank": "82368", 
        "arm_group": [
            {
                "arm_group_label": "DF277", 
                "arm_group_type": "Experimental", 
                "description": "Two administrations daily for 7 days"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Two administrations daily for 7 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the safety and efficacy of DF277 for the treatment\n      of otic eczema."
        }, 
        "brief_title": "Clinical Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in the Treatment of Otic Eczema", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Otic Eczema", 
        "condition_browse": {
            "mesh_term": "Eczema"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  12 years or older\n\n          -  Clinical diagnosis of otic eczema suitable for local treatment\n\n        Exclusion Criteria:\n\n          -  Other diseases."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": {
            "#text": "135", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01996748", 
            "org_study_id": "DF277OTIII/11ES01"
        }, 
        "intervention": [
            {
                "arm_group_label": "DF277", 
                "description": "Two administrations daily for 7 days", 
                "intervention_name": "DF277", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Two administrations daily for 7 days", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Esplugues de Llobregat", 
                    "country": "Spain", 
                    "state": "Barcelone", 
                    "zip": "08950"
                }, 
                "name": "Laboratorios SALVAT, S.A."
            }
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicenter, Randomized, Parallel, Double-blind, Clinical Trial Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in Patients With Otic Eczema", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The analysis of the itching change at the end of treatment (mean itching on days 4-8 compared to baseline).", 
            "measure": "Analysis of the itching change at the end of treatment.", 
            "safety_issue": "No", 
            "time_frame": "Baseline and days 4-8"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01996748"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Change in itching at follow-up (mean itching on days 9-15 compared to baseline).\nChange in mean scores of otoscopic signs (erythema, edema and scaling) at the end of treatment (day 8) compared to baseline (day 1).\nChange in mean scores of otoscopic signs (erythema, edema and scaling) at follow- up (day 15) compared to baseline (day 1).", 
            "measure": "Change in signs/ symptoms", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 2 weeks"
        }, 
        "source": "Salvat", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Salvat", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}